Search for Clinical Trials

Cerevel has begun a study of an investigational drug called CVL-751 (also known as Tavapadon) as a possible treatment for Parkinson's disease.  …
  • Psychiatry and Behavior
Essential Tremor: A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled study of botox for the treatment of upper limb essential tremor…
  • Psychiatry and Behavior
Introduction: The melanocortin-4 receptor (MC4R) pathway is the principal regulator of mammalian energy balance and body weight. Originating in the…
  • Endocrinology
  • Genetic and Rare Diseases - Treatment
  • Pediatrics
The Study: Along with our research partners at Quadrant Biosciences and Autism Speaks, we are looking for children who present signs of being on the…
  • Autism
  • Genetic and Rare Diseases - Observational and Gene Discovery
  • Growth and Development
  • Pediatrics
Mental illness represents a significant health burden to patients, caregivers and the health system. Despite significant work in the last two decades…
  • Depression and Mood Disorders
  • Psychiatry and Behavior
Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Response study of Sage-324 for the treatment of Essential Tremor The purpose of this…
  • Psychiatry and Behavior
The purpose of this research study is to investigate a potential treatment for quitting smoking and preventing post-quit weight gain. This study will…
  • Asthma/COPD
  • Cancer - Lung
  • Lung
A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With a History of HeFH (…
  • Lipids and Cholesterol
This is a laboratory-based research protocol in which prospectively collected specimens of endometriotic tissue and a sample of whole blood will be…
  • Obstetrics and Gynecology
This proposal will identify and evaluate genomic biomarkers found in menstrual fluid for the development of a non-invasive diagnostic test for…
  • Obstetrics and Gynecology
Back to topback-to-top